Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of Platelet Rich Plasma Drops to Moderate Clinically Significant Dry Eye
Sponsor: University of Rochester
Summary
This is a single center double-masked study with up to four visits. Subjects who have been diagnosed with dry-eye syndrome at Flaum Eye Institute will be enrolled. The purpose of the study is to determine if using platelet rich plasma drops can improve clinically significant dry eye in patients and determine if there is a difference with using two different uses of the plasma tear drops: platelet rich plasma tears and plasma tears without platelets.
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2025-10-15
Completion Date
2026-12-15
Last Updated
2024-11-26
Healthy Volunteers
No
Conditions
Interventions
Platelet Poor Plasma Tear Drops
Participant blood will be drawn and processed by the University of Rochester Transfusion Medicine and Blood Bank. Processing will isolate the platelet free fraction of the blood plasma. After processing, plasma should contain ≤ 5% concentration of white blood cells (WBC), red blood cells (RBC), and platelets when compared to the concentration before processing.
Platelet Rich Plasma Tear Drops
Participant blood will be drawn and processed by the University of Rochester Transfusion Medicine and Blood Bank. Processing will isolate the platelet fraction of the blood plasma. After processing, plasma should contain ≤ 5% concentration of WBC and RBC and 100 x 10³ μl or ≥ 50% recovery of platelets when compared to the pre-platelet count.
Locations (1)
Flaum Eye Institute at the University of Rochester
Rochester, New York, United States